The combined company will expand access to home and ambulatory infusion therapy across the U.S. with a focus on patient-centered care and clinical excellence.
Shore Capital Partners, a Chicago-based private equity firm with offices in Nashville, announced the merger of Reliant Healthcare and Care Fusion Rx, a platform investment of Shore Capital’s Healthcare Advantage Fund. The unified infusion therapy platform is designed to deliver comprehensive services across both home and ambulatory settings.
Health Technology Insights: TurnOnGreen to Power New High-Precision Medical Laser
“We are thrilled to partner with Reliant and Care Fusion to build a differentiated infusion platform focused on quality, access, and growth.” Mike Cooper, Partner, Shore Capital
The combined company will be led by an experienced team of industry veterans committed to expanding access to infusion therapies nationwide. Together, Reliant and Care Fusion share a mission to improve the patient experience and partner with physicians and payors to deliver consistent, safe, and cost-effective treatment.
Health Technology Insights: Lipocine Reports Positive Phase 3 Safety for LPCN 1154
Founded in 2008, Reliant is a leading provider of home infusion therapy and ambulatory infusion center services, operating 14 centers and multiple specialty pharmacies across Louisiana, Texas, and Oklahoma. Founded in 2020, Care Fusion is a California-based infusion therapy company focused on complex therapies. Together, the companies serve thousands of patients at the local level and across conditions such as neurology, immunology, oncology, rare disease, rheumatology, and gastroenterology.
“This partnership represents a tremendous opportunity to enhance how and where patients receive infusion therapy,” said Brad Smith, CEO of Reliant Healthcare. “By combining two organizations with deep clinical expertise and shared values, we are creating a platform capable of delivering even more consistent, accessible, affordable, and compassionate care to patients who rely on these therapies every day.”
“At Care Fusion, our focus has always been on providing patients with the highest level of care and service,” said Wayne Nash, Co-Founder of Care Fusion Rx. “Joining forces with Reliant allows us to extend that commitment to more patients, leverage our combined operational strengths, and continue improving outcomes for individuals living with chronic and rare conditions,” added Steve Roberts, Co-Founder of Care Fusion Rx.
Together, the organizations combine complementary strengths in home and ambulatory infusion care, uniting Reliant’s established presence across the South with Care Fusion’s leadership in advanced immunoglobulin treatments throughout the West Coast. The platform company is well-positioned to drive national care through new center openings, home infusion territory expansion, and strategic acquisitions in both high-growth and underserved infusion markets.
“We are thrilled to partner with Reliant and Care Fusion to build a differentiated infusion platform focused on quality, access, and growth,” said Mike Cooper, Founding Partner at Shore Capital Partners. “This combination brings together exceptional teams who share a passion for patient care and clinical excellence,” said AJ Gauthier, Principal at Shore Capital Partners.
Frank Alderman, M.D., Co-Founder and Former CEO of MedExpress, will serve as Lead Independent Director of the platform. “We are building a best-in-class, omnichannel platform focused on providing access to high-quality, patient-centric care while optimizing the site of service. Our compelling value proposition spans the spectrum of patients, providers, payors, health systems, and pharma organizations,” said Frank.
Health Technology Insights: InteliChart Launches InteliSense to Power a New Era of Patient Engagement
To participate in our interviews, please write to our HealthTech Media Room at info@intentamplify.com
Source- businesswire
